机器人辅助胸腔镜食管切除术联合全纵隔淋巴结清扫治疗食管鳞癌的肿瘤学结局
本研究回顾性分析了115例2006至2014年接受机器人辅助胸腔镜食管切除术(RATE)且未行新辅助治疗的食管鳞癌(ESCC)患者,评估肿瘤学结局及全纵隔淋巴结清扫(ML)的效果。结果显示3年总生存率(OS)为85.0%,无复发生存间隔(RFI)为79.4%,R0切除率95.7%,平均清扫淋巴结49.0枚,手术死亡率3.5%。结论认为RATE肿瘤学结局可接受,推荐全纵隔淋巴结清扫尤其对上、中段ESCC。
要点
- RATE联合全纵隔淋巴结清扫治疗ESCC的3年OS为85.0%,RFI为79.4%。
- R0切除率95.7%,平均清扫淋巴结49.0±1.9枚,手术死亡率3.5%。
- 上、中段ESCC应重点清扫双侧喉返神经旁淋巴结,下段应清扫胃左及贲门旁淋巴结。
核心结论
- RATE的肿瘤学结局可接受,推荐行全纵隔淋巴结清扫,尤其对上段或中段ESCC应清扫喉返神经旁淋巴结。
研究设计与样本
- 回顾性队列研究,纳入2006至2014年接受RATE且未行新辅助治疗的115例ESCC患者。
主要发现
- 男性占92.2%,平均年龄63.2±0.8岁;肿瘤位于上段12例(10.4%)、中段59例(51.3%)、下段44例(38.3%)。
- R0切除110例(95.7%),平均清扫淋巴结49.0±1.9枚,手术死亡4例(3.5%)。
- 111例存活患者平均随访32.4±2.2个月,3年OS为85.0%,RFI为79.4%。
- 3年OS和RFI:I期分别为94.4%和96.2%,II期分别为86.2%和80.1%,IIIA期分别为77.8%和79.5%。
- 上、中段ESCC双侧喉返神经旁淋巴结及下段ESCC胃左和贲门旁淋巴结的疗效指数(EI)较高。
临床怎么用
- 对于上段或中段ESCC,行RATE时应重点清扫双侧喉返神经旁淋巴结。
- 对于下段ESCC,应重点清扫胃左及贲门旁淋巴结。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The oncologic outcome of esophageal squamous cell carcinoma (ESCC) patients after robot-assisted thoracoscopic esophagectomy (RATE) with total mediastinal lymphadenectomy (ML) has not been reported. This study was performed to determine the oncologic outcome of RATE and the effectiveness of total ML for ESCC. METHODS: The 115 patients who underwent RATE without neoadjuvant therapy from 2006 to 2014 were reviewed. The efficacy index (EI) was calculated by multiplying the incidence of metastasis by the 3-year survival rate of the patients for each node station. RESULTS: The majority of patients were male (92.2%), and the mean age was 63.2 ± 0.8 years. Tumor location was the upper esophagus in 12 patients (10.4%), the middle esophagus in 59 patients (51.3%), and the lower esophagus in 44 patients (38.3%). R0 resection was achieved in 110 (95.7%) patients; the mean number of dissected nodes was 49.0 ± 1.9. Operative mortalities were 4 (3.5%) cases; in the remaining 111 patients, the mean follow-up time was 32.4 ± 2.2 months. Overall survival (OS) and recurrence-free interval (RFI) at 3 years were 85.0% and 79.4%, respectively. The 3-year OS and RFI were 94.4% and 96.2% in patients with stage I disease, 86.2% and 80.1% in stage II disease, and 77.8% and 79.5% in stage IIIA disease, respectively. High EI values were determined in the bilateral recurrent laryngeal nerve (RLN) nodes in upper and middle ESCC, and in the left gastric and paracardial nodes in lower ESCC. CONCLUSIONS: The oncologic outcome of RATE was acceptable. Total ML, including dissection of the RLN nodes, is recommended especially in upper or middle ESCC.
引用
- Park SY, Kim DJ, Do YW, et al. The Oncologic Outcome of Esophageal Squamous Cell Carcinoma Patients After Robot-Assisted Thoracoscopic Esophagectomy With Total Mediastinal Lymphadenectomy. Ann Thorac Surg. 2016. PMID: 27938889. doi:10.1016/j.athoracsur.2016.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。